Akebia Therapeutics: Buy This Undervalued Stock At Just 77% Of Revenue Seeking Alpha, 29 May 2023 Summary Akebia Therapeutics Inc. is rated a Strong Buy due to its overly discounted revenue and strong prospects in the large…